Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,072 public trials 579 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Recruiting

A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

NCT06932562

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Flinders Medical Centre Adelaide, Australia
  • Box Hill Hospital Box Hill, Australia
  • Canberra Hospital Canberra, Australia
  • Barwon Health, University Hospital Geelong Geelong, Australia
View all 59 locations
View Trial Details
Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

NCT04988555

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations
  • Hoag Family Cancer Center Newport Beach, California, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 104 locations
View Trial Details
Recruiting

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

NCT05734196

Conditions
ATP-Binding Cassette Subfamily C Member 6 Deficiency, Arterial calcification of infancy, Autosomal Recessive Hypophosphatemic Rickets, +18 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT04830137

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
View all 16 locations
View Trial Details
Recruiting

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

NCT05272826

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • NL Health Services St. John's, Newfoundland and Labrador, Canada
  • QEII Health Science Centre Halifax, Nova Scotia, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details
Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06153251

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 19 locations
View Trial Details

Related conditions